| Financial Year |
March 31 2023 |
| Monetary Funds |
12,007,159,819.04 |
| Held-for-trading Financial Assets |
1,470,000.00 |
| Notes Receivable |
731,059,874.97 |
| Accounts Receivable |
14,525,756,307.21 |
| Advances to Suppliers |
123,513,410.25 |
| Other Receivables |
373,935,425.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
5,246,599.67 |
| Inventories |
6,822,167,778.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
469,483,003.09 |
| Other Current Assets |
880,144,878.33 |
| Total Current Assets |
36,805,292,504.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,347,575,513.41 |
| Long-term Equity Investment |
1,392,797,739.50 |
| Investment Properties |
417,462,226.90 |
| Fixed Assetes |
4,555,578,078.13 |
| Under-construction Projects |
532,553,763.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
590,691,338.11 |
| R&D expenses |
-- |
| Goodwill |
6,615,294.18 |
| Long-Term Deferred and Prepaid Expenses |
129,852,560.68 |
| Deferred Income Tax Assets |
1,043,873,233.95 |
| Other Non-Current Assets |
98,102,517.04 |
| Sub-Total of Non-Current Assets |
11,469,661,153.63 |
| Total Assets |
48,274,953,657.76 |
| Short-Term Loans |
676,535,864.28 |
| Trading Financial liabilities |
1,662,704.05 |
| Notes Payable |
3,819,379,691.63 |
| Accounts Payable |
4,785,099,812.87 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
775,648,195.62 |
| Taxes Payable |
293,764,703.12 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
920,057,453.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,574,521,241.97 |
| Other Current Liabilities |
153,756,546.61 |
| Sub-Total of Current Liabilities |
15,122,920,874.42 |
| Long-term Loans |
427,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
233,779,057.26 |
| Deferred Income Tax Liabilities |
1,845,192.89 |
| Other Non-Current Liabilities |
162,499,556.15 |
| Sub-Total of Non-Current Liabilities |
1,189,606,965.28 |
| Total Liabilities |
16,312,527,839.70 |
| Paid-In Capital(Or Share Stock) |
3,326,264,570.00 |
| Capital Surplus |
8,894,722,588.52 |
| Surplus Reserve |
1,553,691,005.92 |
| LESS:Treasury Stock |
609,859,632.00 |
| Undistributed Profits |
18,368,005,969.51 |
| Minority Stockholder's Interest |
387,344,091.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
31,575,081,726.82 |
| Owner's Equity（Stockholder's Equity） |
31,962,425,818.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
48,274,953,657.76 |
